Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 111, Issue 12, Pages 2328-2341
Publisher
Springer Nature
Online
2014-10-17
DOI
10.1038/bjc.2014.542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic Susceptibility to Triple-Negative Breast Cancer
- (2013) K. N. Stevens et al. CANCER RESEARCH
- Annexin A2 Heterotetramer: Structure and Function
- (2013) Alamelu Bharadwaj et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Annexin A2 depletion delays EGFR endocytic trafficking via cofilin activation and enhances EGFR signaling and metastasis formation
- (2013) M de Graauw et al. ONCOGENE
- Identification of annexin II as a novel secretory biomarker for breast cancer
- (2013) You Rim Jeon et al. PROTEOMICS
- Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment
- (2012) S. D'Souza et al. BLOOD
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- The association of annexin A2 and cancers
- (2012) Xiaohui Zhang et al. Clinical & Translational Oncology
- Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer
- (2012) Praveenkumar K. Shetty et al. PLoS One
- Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model
- (2011) Meena Sharma et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology
- (2011) Suzanne A. Eccles INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Disruption of the Interface between the Pleckstrin Homology (PH) and Kinase Domains of Akt Protein Is Sufficient for Hydrophobic Motif Site Phosphorylation in the Absence of mTORC2
- (2011) Noel A. Warfel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipid Raft Endocytosis and Exosomal Transport Facilitate Extracellular Trafficking of Annexin A2
- (2011) Mallika Valapala et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events
- (2011) M. Valapala et al. JOURNAL OF CELL SCIENCE
- The annexin A2 system and vascular homeostasis
- (2011) Elle C. Flood et al. VASCULAR PHARMACOLOGY
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation
- (2010) Meena Sharma et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Annexins — Modulators of EGF receptor signalling and trafficking
- (2009) Thomas Grewal et al. CELLULAR SIGNALLING
- Resistance to Trastuzumab in Breast Cancer
- (2009) P. R. Pohlmann et al. CLINICAL CANCER RESEARCH
- Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy
- (2009) Suebwong Chuthapisith et al. EUROPEAN JOURNAL OF CANCER
- What’s positive about ‘triple-negative’ breast cancer?
- (2009) Sara A Hurvitz et al. Future Oncology
- Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects
- (2009) Kamala Kesavan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anxa2 Plays a Critical Role in Enhanced Invasiveness of the Multidrug Resistant Human Breast Cancer Cells
- (2009) Fei Zhang et al. JOURNAL OF PROTEOME RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More